- May 23, 2018 Spero Therapeutics Announces Positive Top-Line Data for Two Product Candidates from its Potentiator Platform
- May 10, 2018 Spero Therapeutics Announces First Quarter 2018 Financial Results and Pipeline Update
- May 01, 2018 Spero Therapeutics to Present at Bank of America Merrill Lynch Health Care Conference in May
- April 16, 2018 Spero Therapeutics Highlights SPR741 Phase 1 and Preclinical Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases
- April 12, 2018 Spero Therapeutics Appoints Ian A. Critchley, Ph.D., as Head of Clinical Microbiology
- April 02, 2018 Spero Therapeutics Announces Fourth Quarter and Full Year 2017 Operating Results and Provides Pipeline Update
- March 22, 2018 Spero Therapeutics to Present at Upcoming Investor Conferences
- March 01, 2018 Spero Therapeutics to Present at March Investor Conferences
- February 01, 2018 Spero Announces Appointment of David P. Southwell to its Board of Directors
- January 04, 2018 Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer
Displaying 31 - 40 of 83 results